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Cardiovascular functions, including blood pressure and vascular functions, exhibit diurnal 
oscillation. Circadian variations have been clearly shown in the occurrence of 
cardiovascular events such as acute myocardial infarction. Circadian rhythm strongly 
influences human biology and pathology. The identification and characterization of 
mammalian clock genes revealed that they are expressed almost everywhere throughout the 
body in a circadian fashion. In contrast to the central clock in the suprachiasmatic nucleus 
(SCN), the clock in each tissue or cell is designated as a peripheral clock. It is now 
accepted that peripheral clocks have their own roles specific to each peripheral organ by 
regulating the expression of clock-controlled genes, although the oscillation mechanisms of 
the peripheral clock are similar to that of the SCN. However, little was known about how 
the peripheral clock in the vasculature contributes to the process of cardiovascular disorders. 
The biological clock allows each organ or cell to anticipate and prepare for changes in 
external stimuli. Recent evidence obtained using genetically engineered mice with 
disrupted circadian rhythm showed a novel function of the internal clock in the 
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pathogenesis of endothelial dysfunction, hypertension and hemostasis. Loss of 
synchronization between the central and peripheral clock also contributes to the 
pathogenesis of cardiovascular diseases since restoration of clock homeostasis could 
prevent disease progression. Identification of clock-controlled genes in each organ, as well 
as discovery of tools to manipulate the phase of each biological clock, will be of great help 




It is well known that some cardiovascular physiological functions such as heart rate (HR) 
and blood pressure (BP) exhibit apparent circadian variation. In addition, many 
cardiovascular disorders occur in a circadian fashion. For example, acute myocardial 
infarction (AMI) and cerebral infarction most often occur in the early morning whereas 
subarachnoid hemorrhage and a subtype of atrial fibrillation are usually seen in the 
afternoon. The diurnal variation in cardiovascular events is believed to be the consequence 
of both external and internal biological clock rhythms. Most of these disorders, once they 
happen, can be fatal or induce severe damage; therefore, it is important to elucidate the 
precise mechanism of the onset of such diseases to establish a preventive strategy. In this 
article, we would like to review the role of the molecular clock in the pathogenesis of 
vascular diseases. 
 
Molecular clock in mammalian cells  
Accumulating evidence has elucidated the molecular mechanisms of the circadian clock 1-4. 
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Several positive and negative feedback loops exist in the biological clock at transcriptional 
and post-translational levels. Among them, the core negative feedback loop comprises 
positive limb (CLOCK, NPAS2, BMAL1 and CLIF/BMAL2) proteins and negative limb 
(three period, PER1, PER2, PER3 and two cryptochrome, CRY1, CRY2) proteins. Most are 
basic helix-loop-helix (bHLH)/per-arnt-sim (PAS) domains containing transcription factors. 
CLOCK or NPAS2 forms a heterodimer with BMAL1 or CLIF/BMAL2 and binds to the 
E-box element with CACGTG sequences upstream of the per or cry gene 2. They enhance 
the transcription of per and cry, and the PER protein forms a complex with the CRY protein 
and inhibits CLOCK/BMAL-mediated transcription of the per or cry gene itself, therefore 
resulting in a negative feedback loop (Figure 1). PER proteins are also phosphorylated with 
serine-threonine kinase casein kinase 1 epsilon (CK1ε) and degraded by the proteasomal 
pathway 5. Thus, post-translational mechanisms, including phosphorylation and 
ubiquitination, also control the timing of the circadian clock 6. In contrast to the ubiquitous 
expression of BMAL1, CLIF/BMAL2 is mainly expressed in vascular endothelial cells 7. 
However little is known about the redundancy or the dynamic function of BMALs in the 
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vasculature, although CLIF/BMAL2 was shown to have a higher affinity to PER2 than 
BMAL1 8.  
In addition to this core feedback loop, the nuclear receptor REV-ERBα is also 
transactivated by the CLOCK/BMAL1 heterodimer. The REV-ERBα protein represses 
bmal1 transcription, which is essential for circadian bmal1 expression. Another feedback 
loop includes the bHLH domain containing transcription factors, deleted in esophageal 
cancer (dec1, dec2). The heterodimer of CLOCK and BMAL1 binds to the E-box upstream 
of dec1 and dec2, and activates their transcription. DEC proteins in turn repress the 
transcriptional activity of CLOCK/BMAL1, thus forming another negative feedback loop. 
The CLOCK/BMAL1 heterodimer binds to the E-box upstream of not only the per or cry 
gene, but also to other target genes designated as clock-controlled genes (CCGs). The 
CCGs include arginine vasopressin (AVP), wee1 or other target genes, and mediate the 
rhythmicity of the biological clock and account for the circadian variation in humoral or 
metabolic functions. The CCGs also comprise three proline- and acid-rich (PAR) basic 
leucine zipper (bZip) transcription factors, D-element binding proteins (dbp), hepatic 
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leukemia factor (hlf), and thyrotrophic embryonic factor (tef) 4. In addition to 
CLOCK/BMAL1, PAR transcription factors also induce the circadian expression of CCGs 
and therefore act as mediators or amplifiers of CLOCK/BMAL-induced CCG expression. 
The induction of CCG expression is antagonized by another bHLH transcription factor, 
E4BP4 9, which is induced by REV-ERBα. The phase of the three PAR transcription factors 
are antiphase to that of E4BP4, resulting in the circadian expression of CCGs. 
The center of the biological clock, that is, the central clock, exists in the 
suprachiasmatic nucleus (SCN) in the hypothalamus 3. The central clock regulates 
physiological functions through the autonomic nervous system, humoral mediators or 
unknown factors. The phases of the internal clock can be entrained by external stimuli. 
Zeitgebers (timekeepers) are factors that could reset the rhythm. Clock genes express in a 
circadian fashion in SCN, and light is the main zeitgeber for the central clock and can reset 
the phase of its rhythm. In addition to the central clock, circadian expression of clock genes 
can be detected in each peripheral organ or cell, suggesting that each organ has its own 
internal clock. This clock system is called the peripheral clock in contrast to the central 
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clock in the SCN (Figure 2). The molecular mechanism of the peripheral clock is 
considered to be similar to that of the central clock 10,11. The central clock synchronizes each 
of the peripheral clocks within the body 1; however, little is known about how peripheral 
clocks are regulated by the central clock. In contrast to the central clock, the phase of the 
peripheral clock cannot be entrained with light; thus, the phases of each peripheral clock 
seem to be synchronized by neuronal or other unknown humoral factors derived from the 
SCN. Finding the appropriate zeitgeber for each organ will help not only in understanding 
the clock system, but also in establishing a novel type of therapeutic approach, named 
chronotherapy.  
 
Molecular/peripheral clock in vasculature  
The existence of a peripheral clock system in each organ or cell was demonstrated using in 
vitro cultured fibroblasts 10. Balsalobre et al. stimulated fibroblasts with 50% serum for a 
short time and observed the circadian oscillation of clock gene expression. A single cell in 
culture has its own oscillation rhythm, whereas cell populations in in vitro culture are 
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usually arrhythmic because of the asynchronous circadian rhythm among cells 12. However, 
once a phase-aligning stimulus such as 50% serum is applied, they start to show uniform 
circadian rhythm 13. 
Diurnal variation in clock genes was also reported in cardiac organs including the 
heart, aorta and kidney 14,15. A study based on microarray analysis revealed that about 
8-10% of genes show circadian expression in the heart and liver; however, most of these 
genes are organ specific 16. Therefore, in addition to the central clock in the SCN, a 
peripheral clock in each organ seems to regulate tissue-specific physiological functions, and 
identification of peripheral CCG will greatly help in understanding the role of the 
biological clock in cardiovascular organs 17.  
In order to prove the existence of an intrinsic clock system in cardiovascular 
tissues, we studied the clock gene expression of in vitro cultured vascular endothelial cells 
and confirmed the circadian clock gene expression 18. We also searched for CCGs in 
vascular endothelial cells and identified circadian expression of thrombomodulin, a 
membrane protein with anti-coagulant activity. Vascular smooth muscle cells also possess 
 10 
an intrinsic biological clock. In addition to serum shock, angiotensin II (AngII) or retinoic 
acid also induced circadian clock gene expression, suggesting that AngII or retinoic acid 
can function as a zeitgeber 15,19. Chalmers et al. identified the tissue inhibitor of 
metalloproteinase 1 and 3, collagen 3a1, transgelin1 (sm22α) and calponin1 exhibit 
circadian expression in smooth muscle cell line (Movas-1) 20. Several vascular functions 
have been shown to exhibit circadian rhythm, including endothelium-dependent 
vasodilatory function 21,22. In human subjects, endothelial function measured by 
flow-mediated dilation was shown to have circadian oscillation with lower function in the 
morning 23.  
Recent evidence has illuminated the roles of the molecular clock in endothelial 
functions. Mice with the Per2 mutation produced lesser amounts of nitric oxide and 
vasodilatory prostaglandins and more cyclooxygenase-1 derived vasoconstrictors than the 
wild type, resulting in impaired endothelium-dependent relaxation in response to 
acetylcholine 24. Endothelial dysfunction was also seen in mice with Bmal1 Knockout (KO) 
and CLOCKmut 25. Akt signaling and nitric oxide production were reduced in Bmal1 KO 
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arteries, and those arteries became more susceptible to thrombosis formation. The release of 
hematopoietic stem cells or endothelial progenitor cells (EPCs) from bone marrow is 
regulated by circadian rhythm 26. In a diabetic state, a disrupted peripheral clock caused by 
bone marrow neuropathy impaired circadian release of EPCs from bone marrow and 
exacerbated diabetic retinopathy 27. Per2 mutant mice also had impaired EPC mobilization 
function 28. EPC mobilization in response to ischemia or VEGF stimulation was reduced in 
Per2 mutant mice compared with wild-type mice. EPCs from Per2 mutant mice exhibit 
greater senescence together with Akt activation and impaired angiogenesis in a hind-limb 
ischemia model. Transplantation of wild-type bone marrow into Per2 mutant mice 
prevented autoamputation in Per2 mutant mice. Both Bmal1 KO and Per2 mutant mice had 
endothelial dysfunction; however, the opposite effect was observed with respect to Akt 
activation. This may be related to the different roles of these clock genes in the core loop 
formation; that is, Bmal-1 is a positive limb protein whereas Per2 works as a negative limb 
protein. Senescence also affects the biological clock function. Kunieda et al. revealed that 
circadian expression of clock genes are attenuated in senescent human smooth muscle cells 
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(HSMCs) 29. Telomere shortening and impaired cAMP response element-binding protein 
(CREB) activation accounted for the loss of circadian rhythmicity in senescent cells, since 
the introduction of telomerase or restoration of CREB effected a complete recovery of the 
circadian rhythm. 
 
Blood pressure/hypertension and the molecular clock 
In the normal subjects, BP declines during nighttime, begins to rise in early hours of the 
morning and reaches near peak or peak values at mid-morning 30,31. A number of factors can 
influence the diurnal variation in BP, including the autonomic nervous system 32, vasoactive 
intestinal peptide 33, plasma renin activity 34, aldosterone 35 and plasma atrial natriuretic 
peptide (ANP) 36. It is well known that sympathetic activity as well as 
renin-angiotensin-aldosterone activity peaks in the morning 32,37. BP is also affected by 
external factors such as physical activity, emotional state, eating and the sleep/wake cycle. 
Results of a study in humans indicated that disharmony in the circadian rhythm can cause 
hypertension 38. Human subjects kept under a protocol of circadian misalignment with 
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behavioral cycle 28 hours instead of 24 hours, demonstrated mild but significant 
hypertension.  
A decade ago, Janssen et al. studied the role of the internal clock in the rhythm of 
BP. Lesioning of the rat SCN abolished the circadian rhythm of BP and HR without 
affecting the 24-hour cycle of locomoter activities 39. Recent evidence has provided much 
deeper insights into the role of the molecular clock in BP regulation. Global deletion of 
Bmal1 completely abolished the diurnal variation in BP 40. Bmal1 mutant mice also exhibits 
hypotension together with reduced production of catecholamines. Global Per2 mutant mice 
also exhibits lower BP 24. In contrast, the endothelial-specific deletion of Bmal1 did not 
affect the variation in BP, suggesting that the peripheral clock in endothelial cells does not 
solely induce diurnal BP rhythm 41. A genetic association study demonstrated that a single 
nucleotide polymorphism within the bmal1 promoter is associated with hypertension and 
type 2 diabetes 42, providing support that the molecular clock is involved in the 
pathogenesis of metabolic disorders. Recent evidence supported the contribution of PPARγ 
in the clock system. PPARγ binds to the promoter upstream of bmal1 and induces its 
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transcription 43. The expression of PPARγ also exhibited circadian oscillation in the aorta, 
and an endothelial- or vascular smooth muscle cell-specific deletion of PPARγ attenuated 
the BP variation together with reduced catecholamine production. 
Plasma aldosterone concentration has a diurnal variation with the peak during 
night hours 35. One of the adrenal enzymes involved in aldosterone production, type VI 
3β-hydroxyl-steroid dehydrogenase (Hsd3b6), exhibits circadian expression in normal 
subjects. However, Cry1/2-null mice had a constitutive high expression of Hsd3b6 together 
with overproduction of aldosterone from adrenal glands, which resulted in salt-sensitive 
hypertension in Cry1/2-null mice 44. Aldosterone regulates the expression of the 
alpha-subunit of the epithelial sodium channel (αENaC) mRNA through the Per1-mediated 
pathway 45. αENaC is known to affect systemic BP; therefore these findings suggest a novel 
function of the molecular clock during the pathogenesis of hypertension.  
 
Acute myocardial infarction and the circadian clock 
Beginning a few decades ago, it became well known that AMI or thrombotic events such as 
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pulmonary embolism frequently occur in the early morning 46,47. Since these disorders can 
be fatal, elucidating the mechanisms of circadian onset of cardiovascular disorders will help 
not only for a better understanding of their pathogenesis but also for establishing preventive 
strategies 48. In this section, we would like to discuss how the biological clock contributes 
to the onset of thromboembolic events. 
Diurnal activation of the autonomic nervous system seems to contribute to the 
circadian onset of cardiovascular events. A morning increase in ischemic events was not 
observed in patients with autonomic nervous dysfunction induced by diabetes 49. In addition, 
patients receiving β-blockers did not demonstrate morning increase of ischemic heart 
attacks 50. Several cardiovascular and hematologic functions are related to the circadian 
onset of cardiovascular events, including BP, HR, coronary blood flow, platelet function, 
blood coagulability and fibrinolytic activity 48. In the early morning, BP and HR increase 
and enhance the demand for oxygen by the heart 51. In contrast, the vascular tone of 
coronary arteries increases and, therefore, coronary blood flow decreases in the morning 52, 
resulting in a mismatch of oxygen demand and supply during this period. Coronary 
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segments with endothelial dysfunction exhibit circadian vasomoter activity, whereas 
segments with normal endothelial function did not demonstrate circadian variations, 
suggesting a potential protective role of endothelial function in coronary events 53. 
Moreover, both platelet aggregation and blood coagulability increase 54 whereas fibrinolytic 
activity decreases in the morning. These hypercoagulability and hypofibrinolytic activities 
also elicit the morning onset of thromboembolic events.  
Not only platelet aggregation activity, but also the number of circulating platelets 
have circadian oscillation 55,56. Platelets are activated by catecholamines, which are secreted 
from the autonomic nervous system. However, it is not clear whether the peripheral clock 
directly affects platelet function, since no surface markers characteristic of platelet 
activation have been shown thus far to exhibit circadian expression 55.  
High concentration of coagulation factor VII is considered to be a risk factor for coronary 
artery diseases 57. Circadian oscillation has been shown not only in the factor VII level in 
blood, but also in levels of fibrinogen, prothrombin, factor VIII and tissue factor pathway 
inhibitor, a direct inhibitor of the FXa/TF/FVIIa complex 58,59. Microparticles from 
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endothelium induces coagulation through the tissue factor mediated pathway 60. A recent 
report by Madden et al. showed that the number of vascular cell adhesion molecule-1 
(VCAM-1) positive microparticles in human plasma had a significant diurnal variation with 
a peak at 9 a.m. 61. These findings support the presence of hypercoagulability in the 
morning hours.  
Fibrinolytic activity also was shown to have circadian variation with a peak in the 
afternoon and trough in the early morning, which is an antiphase to that of coagulation 
activity 62-64. The level of plasmin-plasmin inhibitor complex, a marker of intravascular 
plasmin generation, decreases in the morning. Because of the morning decrease in 
fibrinolytic activity, recovery of patency of occluded coronary vessels by 
tissue-plasminogen activator (tPA) therapy for AMI treatment is more difficult in the 
morning hours 65. The level of tissue plasminogen activator inhibitor-1 (PAI-1), which 
regulates the activity of t-PA, mainly determines fibrinolytic activity. High concentration of 
PAI-1 or t-PA can become a risk factor for the occurrence of a first AMI 66. There is 
circadian oscillation in the concentration and activity of PAI-1 with a morning peak, 
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resulting in reduced t-PA activity during that period 67,68. All these data support the notion 
that circadian oscillation of PAI-1 activity significantly contributes to the formation of a 
diurnal variation in fibrinolytic function. The homeostasis of the coagulation cascade is 
achieved by the balance between coagulation activity and fibrinolytic activity. Activation of 
coagulation is normally accompanied by an increase in fibrinolytic activity. Therefore, the 
mismatch of these two cascades also elicits the morning onset of cardiovascular events. 
The mechanisms of the diurnal variation in PAI-1 activity have been well studied. 
We and other groups analyzed the roles of the molecular clock in circadian PAI-1 activation 
7,69. PAI-1 mRNA and protein levels clearly reflect a circadian rhythm in the heart and aorta 
with a peak expression in the evening. The phase of circadian PAI-1 expression in mice is 
antiphase to that of the human, since humans are diurnal whereas rodents are nocturnal. 
Therefore, PAI-1 expression in rodents also accounts for the human circadian oscillation. 
We have shown that CLIF/BMAL2 forms a heterodimer with CLOCK and binds to the 
E-boxes upstream of the pai-1 gene and transactivates its expression 7. The heterodimer of 
CLOCK/BMAL1 also activates the PAI-1 promoter 70. Oishi et al. showed that a ketogenic 
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diet induces the phase shift of peripheral clock gene expression including PAI-1, suggesting 
that PAI-1 expression is regulated by the peripheral clock 71. Westgate et al. studied the 
susceptibility to thrombotic events using a mouse photochemical injury model and 
observed a diurnal variation in thrombogenicity in this in vivo model 41. CLOCKmut mice 
have lost this dynamic variation. Surprisingly, the endothelial-specific deletion of the 
Bmal1 gene (Bmal1fx/fxCreTek) also abolished the circadian oscillation of thrombogenic 
events; however, diurnal variation in systemic PAI-1 activity was sustained in this mouse 
model. This finding suggests that the peripheral clock within endothelial cells contributes to 
prevention of thrombosis through mechanisms other than those affecting systemic PAI-1 
activity.  
Thrombomodulin has an opposite effect to that of PAI-1 in terms of the 
coagulation cascade; that is, thrombomodulin inhibits thrombin activation and also 
activates protein C 72-74. We revealed that thrombomodulin is expressed with a circadian 
oscillation in vascular endothelial cells 18. The phase of circadian thrombomodulin 
expression is similar to that of PAI-1 with a peak in the morning. Based on these findings, 
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we can raise the hypothesis that circadian expression of thrombomodulin may be beneficial 
in protecting endothelium from diurnal thrombogenic activation induced by PAI-1 
expression. Further studies are required to fully elucidate the role of circadian 
thrombomodulin expression in cardiovascular events. 
 
Roles of the peripheral clock in cardiovascular diseases.  
The central questions related to the molecular clock and cardiovascular diseases are 
whether the biological clock is affected in cardiovascular disorders, and, in turn, whether 
impairment of the molecular clock induces the progression of those diseases. The 
impairment of the peripheral clock in pathology already has been demonstrated in several 
disease models. Young et al. showed that the phase of circadian rhythm of core clock genes, 
such as bmal1, per2 and hlf, was advanced 3 hours in diabetic rats 75. Also, in rat heart with 
pressure-overload hypertrophy, the rhythmic expression of PAR transcription factors (dbp, 
hlf) and anp was markedly reduced 76. Myocardial ischemia/reperfusion (I/R) was also 
shown to affect the circadian clock system. Clock gene oscillations were rapidly diminished 
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in the I/R area of the heart whereas they were not affected in non-ischemic regions. E4BP4 
antagonizes the transcriptional activity of PAR family members, such as DBP, HLF and 
TEF. At the I/R site of the heart, E4BP4 expression was strongly induced, resulting in the 
suppression of circadian pdk4 and ucp3 expression 77. Moreover, aging and hypertension 
were also known to affect the internal circadian rhythm 78,79. 
Several studies have addressed the second question, which is whether an impaired 
circadian clock affects disease progression. Penev et al. repeated phase shifts of the 
Light/Dark (L/D) cycle in cardiomyopathic hamsters and found that disruption of 
rhythmicity strikingly enhanced disease progression and resulted in shortened longevity 80,81. 
Martino et al. also analyzed the effect of impaired rhythm in cardiac hypertrophy 82. They 
performed transverse aortic constriction (TAC) surgery as a murine model of pressure 
overload cardiac hypertrophy, and kept the mice in a rhythm-disruptive 20-hour (L/D 
10:10) or normal 24-hour (L/D 12:12) environment after TAC surgery. Rhythm-disturbed 
TAC animals exhibited decreased left ventricular systolic function together with increased 
perivascular and interstitial fibrosis. Decreased left ventricular function was recovered 
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when the mice were kept under conditions of a normal 24-hour rhythm.  
Martino et al. also performed an elegant study using hamsters with a point 
mutation in the circadian regulatory gene casein kinase-1ε as a heterozygote, termed the 
+/tau mutation. The +/tau heterozygous animals had a reduced circadian period of 22 hours 
with disrupted behavior rhythmicity, and they developed cardiomyopathy and extensive 
cardiac fibrosis, resulting in death at a young age.  However, when these mutant animals 
were maintained under conditions of their own rhythm period (22 hours), the progression of 
the cardiac disorders was reversed. Ablation of the SCN at a young age also rescued the  
cardiac phenotype. There exist two clock systems with different periods in +/tau 
heterozygotes, since their peripheral clock is controlled by the intrinsic 22-hour clock as 
well as the 24-hour cycle from the SCN. Under a 22-hour L/D cycle or an SCN lesioned 
condition, the discrepancy between the central and peripheral clock disappeared together 
with rescue of the cardiac pathology. These results raise the hypothesis that it is not 
disruption of the peripheral clock but disharmony between the external and internal clock 
or between the central and peripheral clock that elicited cardiovascular disorders. Therefore, 
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loss of synchronization between the central and peripheral clock could elicit progression of 
the disease.  
In healthy subjects, the peripheral clock seems to be beneficial for anticipation and 
preparation for external stimuli such as BP rise in the morning. It may help the organ to 
respond rapidly and easily to the environmental change at each time of the day. Mice had a 
diurnal variation in BP with a peak in the evening. In mouse cardiomyocytes, the 
expression of cardioprotective gene anp also results in a diurnal variation with a peak in 
dark phase, which is consistent with high BP periods 76.  
Discrepancy between the two clock systems could occur among peripheral tissues 
as well. In the aorta, the phase of circadian Per2 expression is distinct from the phase in 
SCN, suggesting that the timing of clock rhythm is determined by each peripheral organ 83. 
Davidson et al. reported that the time phases of circadian rhythm in arteries and veins varies 
significantly according to the anatomical location 84. The role of the peripheral clock in 
arteries may be different from that in veins.  
In the acute phase of myocardial infarction, the phase of the circadian clock in the 
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ischemic heart differs from that in the non-ischemic area 77. This discrepancy could elicit 
the incidence of myocardial arrhythmia. These losses of synchronization of circadian 
rhythms between each organ or tissue may occur more frequently than we have expected.  
Resynchronization of the peripheral circadian clock with the environment or within each 
peripheral organ can become a potential target for establishing a novel preventive strategy 
or treatment for cardiovascular diseases. Although angiotensin II, endothelin or 
prostaglandin E2 is known to modify the circadian rhythm 15,85,86, we must identify the 
appropriate zeitgebers (timekeepers) to reset or resynchronize the phase of each clock 
system without directly affecting tissue homeostasis. No direct evidence has been reported 
that catecholamine or nutrients (glucose or fatty acids) could affect the phase of circadian 
clock 87. A recent report revealed that PPARγ induces Bmal1 expression in cardiovascular 
organs 43, suggesting that thiazolidinediones, an agonist of PPARγ, may become a potential 





Each cardiovascular organ or cell has its own peripheral clock together with input from the 
SCN central clock. These peripheral clocks seem to play an important role in the prevention 
of cardiovascular disorders. Identification of CCGs in each organ will provide significant 
insights for an understanding of the precise roles of the peripheral clock. Synchronization 
of clock cycles between the central and peripheral clock, or among peripheral clocks in 
different organs, is also critical for normal health and homeostasis. Failure to harmonize the 
central and peripheral clock or internal and external rhythm could result in progression of 
cardiovascular disorders. Discovery of an appropriate zeitgeber or a small compound that 
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The heterodimer of CLOCK and BMAL1 bind to the E-box elements upstream of period 
(per), cryptochrome (cry), and nuclear receptor Rev-erbα promoters. PER protein 
accumulates in the cytoplasm and translocates into the nucleus forming a complex with 
CRY proteins, then inhibits CLOCK-BMAL1-dependent transcription. Rev-erbα protein 
accumulates quickly and inhibits BMAL1 transcription, resulting in the oscillation of bmal1 
gene expression. CLOCK/BMAL1 heterodimer also binds to the E-box of target genes, 
designated as clock-controlled genes (CCGs). The heterodimer also transactivates 
proline-and acid-rich basic leucine zipper transcription factors, dbp, hlf and tef. These 
transcription factors in turn induce the circadian expression of CCGs. 
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(SCN) in the hypothalamus. Each organ or cell, including the aorta, vascular endothelial 
cells and vascular smooth muscle cells (VSMC), also has circadian expression of clock 
genes and is designated as the peripheral clock. Circadian expression of clock-controlled 
genes (CCGs) are in part regulated directly by the central clock (direct pathway). In 
addition, peripheral clocks in cardiovascular tissues or cells are also stimulated and 
synchronized by the central clock and regulate diurnal expression of (CCGs). 
 
Figure 2.  
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